Fate Therapeutics
FATE
FATE
39 hedge funds and large institutions have $23.9M invested in Fate Therapeutics in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Holders
39
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$37.6K | |
| 2 | +$36K | |
| 3 | +$26.6K | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$25.8K |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$12K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$529K | |
| 3 | -$304K | |
| 4 |
Goldman Sachs
New York
|
-$234K |
| 5 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$139K |